Hybrisil
Product Images NDC 55379-405

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Hybrisil (NDC 55379-405). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Biozone Laboratories, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle Label (Label Cd01)

This is a medication in Gel form used for external use only and it's for RX use only. It is a topical scar treatment containing 1% Methylprednisolone acetate. The net weight is 30g which is indicated by the NDC number 55379-405-30. It is manufactured by Crescendo Therapeutics, LLC and should be stored at room temperature. The text also mentions the patent status and address of the manufacturer.*

FDA Label Image

Chemical Structure (Structure 20110420)

FDA Label Image

Carton Label (Uc Cd01)

HybriSil™ is a product by Crescendo Therapeutics that contains Methylprednisolone acetate 1% in a silicone gel based polymer. It is designed for RX use only, and helps to improve the appearance of scars. It works by softening and flattening raised scars, fades red or dark scars, and relieves itching and discomfort of scars. The product comes in a container with net weight 30g.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.